National Health Investors Stock Probability Of Bankruptcy
| NHI Stock | USD 62.32 0.80 1.30% |
National | Probability Of Bankruptcy |
National Health Investors Company probability of distress Analysis
National Health's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current National Health Probability Of Bankruptcy | Less than 3% |
Most of National Health's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Health Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of National Health probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting National Health odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of National Health Investors financial health.
Is National Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 3.13 | Revenue Per Share 7.384 | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
National Probability Of Bankruptcy Driver Correlations
Understanding the fundamental principles of building solid financial models for National Health is extremely important. It helps to project a fair market value of National Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since National Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of National Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of National Health's interrelated accounts and indicators.
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, National Health Investors has a Probability Of Bankruptcy of 3.0%. This is 92.99% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The probability of bankruptcy for all United States stocks is 92.47% higher than that of the company.
National Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National Health's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National Health could also be used in its relative valuation, which is a method of valuing National Health by comparing valuation metrics of similar companies.National Health is currently under evaluation in probability of bankruptcy category among related companies.
National Health Main Bankruptcy Drivers
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Return On Assets | 0.0342 | 0.0434 | 0.0219 | 0.009197 | 0.0545 | 0.0822 | |
| Net Debt | 1.4B | 1.5B | 1.2B | 1.1B | 1.1B | 1.2B | |
| Total Current Liabilities | 92.9M | 87.6M | 70.2M | 70.0M | 79.4M | 53.2M | |
| Non Current Liabilities Total | 1.5B | 1.5B | 1.3B | 1.1B | 1.1B | 1.2B | |
| Total Assets | 3.0B | 3.1B | 2.8B | 2.5B | 2.5B | 1.3B | |
| Total Current Assets | 463.5M | 437.1M | 505.2M | 379.8M | 364.5M | 257.1M | |
| Total Cash From Operating Activities | 241.0M | 232.1M | 210.9M | 185.3M | 184.5M | 113.1M |
National Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0448 | ||||
| Profit Margin | 0.42 % | ||||
| Operating Margin | 0.63 % | ||||
| Current Valuation | 4.23 B | ||||
| Shares Outstanding | 43.42 M | ||||
| Shares Owned By Insiders | 4.61 % | ||||
| Shares Owned By Institutions | 64.15 % | ||||
| Number Of Shares Shorted | 874.66 K | ||||
| Price To Earning | 13.23 X | ||||
| Price To Book | 2.02 X | ||||
| Price To Sales | 7.92 X | ||||
| Revenue | 319.83 M | ||||
| Gross Profit | 268.98 M | ||||
| EBITDA | 246.88 M | ||||
| Net Income | 134.38 M | ||||
| Cash And Equivalents | 19.29 M | ||||
| Cash Per Share | 0.97 X | ||||
| Total Debt | 1.14 B | ||||
| Debt To Equity | 0.78 % | ||||
| Current Ratio | 2.78 X | ||||
| Book Value Per Share | 33.73 X | ||||
| Cash Flow From Operations | 184.45 M | ||||
| Short Ratio | 4.55 X | ||||
| Earnings Per Share | 3.13 X | ||||
| Price To Earnings To Growth | 1.99 X | ||||
| Target Price | 62.83 | ||||
| Number Of Employees | 26 | ||||
| Beta | 0.98 | ||||
| Market Capitalization | 2.67 B | ||||
| Total Asset | 2.49 B | ||||
| Retained Earnings | 2.47 B | ||||
| Working Capital | 285.14 M | ||||
| Current Asset | 73.06 M | ||||
| Current Liabilities | 52.78 M | ||||
| Annual Yield | 0.06 % | ||||
| Five Year Return | 6.01 % | ||||
| Net Asset | 2.49 B | ||||
| Last Dividend Paid | 3.6 |
About National Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Health Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Health Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
National Health Investors Sentiment
The influence of National Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in National. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to National Health's public news can be used to forecast risks associated with an investment in National. The trend in average sentiment can be used to explain how an investor holding National can time the market purely based on public headlines and social activities around National Health Investors. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
National Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for National Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average National Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on National Health.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards National Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, National Health's short interest history, or implied volatility extrapolated from National Health options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out National Health Piotroski F Score and National Health Altman Z Score analysis. Note that the National Health Investors information on this page should be used as a complementary analysis to other National Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for National Stock analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is National Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 3.13 | Revenue Per Share 7.384 | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.